Trinity Biotech Premier Hb9210 HbA1c Analyzer - 1 eachRecalls & reported problems
Primus Corporation · Hemoglobin A1c assay, Premier Hb9210 HbA1c Analyzer · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05391516744751), received between May 1, 2025 and May 1, 2025 — classified as 1 malfunction.
The most frequently reported specific device problem is “Unexpected Therapeutic Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Unexpected Therapeutic Results1
Patient problems
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 1, 2025Unexpected Therapeutic Results; Unexpected Therapeutic Results
ON (B)(6) 2025, THE CUSTOMER STATED THAT THEY OBSERVED ERROR CODES DURING ONE SHIFT WHILE OPERATING THE PREMIER HB9210 HBA1C SYSTEM, AND THE SAMPLES WERE LEFT FOR THE NEXT SHIFT TO RUN. THE NEXT SHIFT RAN THE QC, WHICH FAILED. THEY THEN PROCEED TO REPLACE THE COLUMNS ON TO THE SYSTEM, RECALIBRATED, AND THEN RAN QC. WITH PASSING QC, PATIENT SAMPLES WERE RAN AND IT WAS OBSERVED THAT 70% OF THE SAMPLES DID NOT MEET "MATCHING" CRITERIA BETWEEN PREMIER HB9210 ANALYZERS. THE CUSTOMER STATES THAT THEIR CRITERIA IS THE SAMPLES MUST MATCH WITHIN 8%, BUT THEY SAID THEY OBSERVED 15-30% VARIATION BETWEEN THE SAMPLES RAN ON THE DIFFERENT ANALYZERS. THE CUSTOMER STATES THAT THEY PERFORMED A LOOK BACK ON PREVIOUSLY RAN PATIENT RESULTS AND OBSERVED 800 SAMPLES THAT DID NOT MEET THEIR "MATCHING" CRITERIA AND THE TESTS WERE REPEATED. TRINITY BIOTECH ARE NOT ABLE TO CONFIRM IF THE PATIENT DATA WAS AUTOMATICALLY RELEASED FROM THEIR LABORATORY INFORMATION SYSTEM (LIS). THE CUSTOMER STATED THAT A NOTIFICATION WAS SENT FOR THE 800 POTENTIALLY DISCREPANT RESULTS. BASED ON THESE NOTIFICATIONS, THE CUSTOMER CLAIMS THAT THEY HAVE BEEN ADVISED THAT SOME PATIENTS HAD BEEN INCORRECTLY PRESCRIBED MEDICATION. CUR
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
MAUDE report 21945095 ↗
Other Assay, Glycosylated Hemoglobin devices
- Atellica CH A1c_E 11097536Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN3 recalls25 reports
- Atellica CH Fruc 11097637Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN2 recalls0 reports
- Tosoh Automated Glycohemoglobin Analyzer HLC-723G8Tosoh Corporation · Assay, Glycosylated Hemoglobin71 reports
- A1CNow®+ Multi-UseTest System (20 count) 3021Polymer Technology Systems, Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall11 reports
- ADVIA® Chemistry FRUC Reagents 10361941Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall0 reports
- DCA™ Systems Hemoglobin A1c Reagent Kit 10311134Siemens Healthcare Diagnostics Inc. · ASSAY, GLYCOSYLATED HEMOGLOBIN1 recall0 reports
- Tinaquant Hemoglobin A1c III 5336163190Roche Diagnostics GmbH · ASSAY, GLYCOSYLATED HEMOGLOBIN45 reports
- Tina-quant Hemoglobin A1cDx Gen.3 08445699190Roche Diagnostics GmbH · ASSAY, GLYCOSYLATED HEMOGLOBIN11 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page